Perrigo Company plc $PRGO Shares Purchased by Legal & General Group Plc

Legal & General Group Plc lifted its position in shares of Perrigo Company plc (NYSE:PRGO) by 34.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 361,383 shares of the company’s stock after purchasing an additional 91,622 shares during the period. Legal & General Group Plc owned about 0.26% of Perrigo worth $5,030,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. EverSource Wealth Advisors LLC lifted its position in shares of Perrigo by 116.0% during the fourth quarter. EverSource Wealth Advisors LLC now owns 1,888 shares of the company’s stock worth $26,000 after purchasing an additional 1,014 shares in the last quarter. Geneos Wealth Management Inc. lifted its position in shares of Perrigo by 439.1% during the first quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock worth $27,000 after purchasing an additional 786 shares in the last quarter. CWM LLC lifted its position in shares of Perrigo by 230.0% during the fourth quarter. CWM LLC now owns 2,191 shares of the company’s stock worth $31,000 after purchasing an additional 1,527 shares in the last quarter. Key Capital Management INC acquired a new position in shares of Perrigo during the fourth quarter worth $36,000. Finally, Jones Financial Companies Lllp lifted its position in shares of Perrigo by 89.1% during the third quarter. Jones Financial Companies Lllp now owns 1,778 shares of the company’s stock worth $38,000 after purchasing an additional 838 shares in the last quarter. 95.91% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on PRGO. Jefferies Financial Group reissued a “hold” rating on shares of Perrigo in a research report on Thursday, February 26th. Weiss Ratings lowered shares of Perrigo from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, May 28th. Canaccord Genuity Group dropped their price target on shares of Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a research note on Friday, February 27th. Finally, Zacks Research upgraded shares of Perrigo from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Perrigo presently has an average rating of “Hold” and a consensus price target of $19.33.

Perrigo Stock Up 0.1%

PRGO stock opened at $10.85 on Monday. The company has a debt-to-equity ratio of 1.45, a current ratio of 2.72 and a quick ratio of 1.59. Perrigo Company plc has a 1-year low of $9.23 and a 1-year high of $28.43. The firm has a fifty day moving average price of $11.07 and a two-hundred day moving average price of $12.51. The firm has a market cap of $1.50 billion, a price-to-earnings ratio of -0.83, a PEG ratio of 1.28 and a beta of 0.51.

Perrigo (NYSE:PRGO) last released its earnings results on Wednesday, May 6th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.04. Perrigo had a negative net margin of 43.50% and a positive return on equity of 9.96%. The firm had revenue of $841.80 million during the quarter, compared to analyst estimates of $1.04 billion. During the same quarter in the previous year, the firm earned $0.60 earnings per share. The firm’s revenue for the quarter was down 7.2% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Research analysts predict that Perrigo Company plc will post 2.12 EPS for the current year.

Perrigo Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Friday, May 29th will be paid a dividend of $0.29 per share. The ex-dividend date is Friday, May 29th. This represents a $1.16 annualized dividend and a yield of 10.7%. Perrigo’s payout ratio is presently -8.85%.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.